BamSEC and AlphaSense Join Forces
Learn More

Werewolf Therapeutics Inc. – Material Contracts

NASDAQ: HOWL    
Share price (10/7/26): $0.92    
Market cap (10/7/26): $44.7 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.52
from S-4 21 pages Lease Between La Jolla Eastgate LLC and Ambros Therapeutics, Inc. Lease
12/34/56
EX-10.51
from S-4 2 pages August 6, 2026 John Jacobs [***] Re: Member of the Ambros Therapeutics Board of Directors Dear John
12/34/56
EX-10.50
from S-4 2 pages August 14, 2026 Scott Robertson [***] Re: Member of the Ambros Therapeutics Board of Directors Dear Scott
12/34/56
EX-10.49
from S-4 14 pages Ambros Therapeutics, Inc. Consulting Agreement Effective Date: October 7, 2024
12/34/56
EX-10.48
from S-4 16 pages Employment Agreement
12/34/56
EX-10.47
from S-4 12 pages May 31, 2026 Michael Cruse via Email Re: Separation Agreement
12/34/56
EX-10.46
from S-4 15 pages Employment Agreement
12/34/56
EX-10.45
from S-4 6 pages March 27, 2026 Keith A. Katkin [***] Re: Amended and Restated Chairperson of the Board Offer Letter Position Compensation You Will Receive a Base Salary at the Rate of $250,000 on an Annualized Basis, Subject to Applicable Payroll Withholdings and Deductions and Payable in Accordance With the Company’s Standard Payroll Practices. as an Exempt Salaried Employee, You Will Not Be Eligible for Overtime Compensation. Equity Awards
12/34/56
EX-10.44
from S-4 16 pages Employment Agreement
12/34/56
EX-10.43
from S-4 15 pages Employment Agreement
12/34/56
EX-10.42
from S-4 18 pages Employment Agreement
12/34/56
EX-10.41
from S-4 16 pages Supply Agreement
12/34/56
EX-10.40
from S-4 66 pages License and Development Agreement Between Abiogen Pharma Spa and Ambros Therapeutics, Inc. December 18, 2024
12/34/56
EX-10.37
from S-4 22 pages Ambros Therapeutics, Inc. Restricted Stock Award Grant Notice
12/34/56
EX-10.36
from S-4 16 pages Ambros Therapeutics, Inc. Stock Option Grant Notice
12/34/56
EX-10.35
from S-4 22 pages Ambros Therapeutics, Inc. 2024 Equity Incentive Plan
12/34/56
EX-10.30
from S-4 5 pages August 25, 2026 Daniel Hicklin Re: Amendment of Retention Agreement I. Retention Period
12/34/56
EX-10.6
from 8-K 22 pages Contingent Value Rights Agreement
12/34/56
EX-10.5
from 8-K 23 pages Registration Rights Agreement
12/34/56
EX-10.4
from 8-K 44 pages Securities Purchase Agreement
12/34/56